• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
water filter
WATER FILTER FOR WATER PURIFIER
DUST BAG
Small dust filter
HUMIDIFIER FILTER
Oil fume adsorption filter

Argentina announces COVID-19 vaccine supply deal with Moderna

firstwordpharmaJuly 09, 2021

Tag: Moderna , COVID-19 , Vaccine

Argentina says it will sign a COVID-19 vaccine supply agreement with Moderna, as the country attempts to ramp up the inoculation of its population and avoid a possible third wave of coronavirus infections, reported the Financial Post.

Argentina announces COVID-19 vaccine supply deal with Moderna

Cabinet chief Santiago Cafiero said a deal would be signed with Moderna on Monday, but did not detail the number of doses being bought or the agreed delivery dates.

Argentina has so far largely built its COVID-19 inoculation program around Russia's Sputnik V vaccine, China's Sinopharm vaccine and AstraZeneca's vaccine.


Previous:Venezuela payment to COVAX received after funds blocked - Gavi

Next:Xilis Raises $70 Million Series A Financing to Advance Diagnostic and Drug Discovery and Development Platform Leveraging Proprietary MicroOrganoSphere Technology

Related News

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

PharmaSourcesOctober 15, 2024

Thrombolytic Science, LLC (TSI), announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for mutant prourokinase, a recombinant fibrinolytic pro-enzyme.

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

PharmaSourcesOctober 15, 2024

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

PharmaSourcesOctober 15, 2024

Argentina announces COVID-19 vaccine supply deal with Moderna | Pharmasources.com

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

PharmaSourcesOctober 15, 2024

BD and ten23 health today announced a collaboration to develop a new way to track prefillable syringes (PFS) using RFID technology.

You may like
More>>

Rabies Vaccine(Vero Cell)for Human use

Rabies Vaccine(Vero Cell)for Human use
Rabies Vaccine for Human Use (Vero Cell), Freeze-dried

Rabies Vaccine for Human Use (Vero Cell), Freeze-dried
Good immunogenicity performance Influenza Vaccine (Split virion)

Good immunogenicity performance Influenza Vaccine (Split virion)
Quadrivalent Influenza Vaccine Hualan Bio

Quadrivalent Influenza Vaccine Hualan Bio
2023-2024 Recommended composition flu vaccine

2023-2024 Recommended composition flu vaccine
Oral Poliomyelitis Attenuated Live Vaccine (Dragee Candy / Liquid)

Oral Poliomyelitis Attenuated Live Vaccine (Dragee Candy / Liquid)
Influenza A (H1N1) Vaccine, (Split, Inactivated)by Hualan biological

Influenza A (H1N1) Vaccine, (Split, Inactivated)by Hualan biological
Influenza Vaccine

Influenza Vaccine
Inactivated influenza vaccine

Inactivated influenza vaccine
High quality of Influenza Vaccine (Split Virion), Inactivated, Quadrivalent

High quality of Influenza Vaccine (Split Virion), Inactivated, Quadrivalent

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service